Prospective, Single-arm, Single-center Phase II Clinical Study of Perioperative Precision Treatment for Locally Advanced Hepatoid Adenocarcinoma of Stomach
Latest Information Update: 17 Jun 2025
At a glance
- Drugs Disitamab vedotin (Primary) ; Gimeracil (Primary) ; Oteracil (Primary) ; Oxaliplatin (Primary) ; Sintilimab (Primary) ; Tegafur (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- Acronyms HASCHANGE01
Most Recent Events
- 11 Jun 2025 Planned initiation date changed from 27 May 2025 to 27 Jun 2025.
- 03 Jun 2025 New trial record